2191 ⎘
Genetically modified animals; Animal model comprising regulated expression system Animal model comprising inducible/conditional expression system, e.g. hormones, tet
METHOD AND ANIMAL MODEL FOR INDUCING BCC TUMORS
#2DNA EDITING USING SINGLE-STRANDED DNA
#3METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES CAUSED BY A CNTNAP1 MUTATION
#4COMPOSITIONS AND METHODS FOR DEFINING OPTIMAL TREATMENT TIMEFRAMES IN LYSOSOMAL DISEASE
#5TRANSGENIC NON-HUMAN ANIMAL GIVING BIRTH TO INDIVIDUALS OF ONLY ONE SEX, AND METHODS FOR PRODUCING SAME
#6COMPOSITIONS AND METHODS FOR MODULATING NEURONAL EXCITABILITY AND MOTOR BEHAVIOR
#7Novel Animal Model for Autoimmune Disease
#8POLY-GLUTAMINE ANDROGEN RECEPTOR KNOCK-IN ANIMAL MODELS, REAGENTS AND METHODS
#9LIVESTOCK ANIMALS WITH IMPROVED GROWTH PERFORMANCE
#10Gene Expression System
#11Non-human animals comprising a humanized coagulation factor 12 locus
#12DNA EDITING USING SINGLE-STRANDED DNA
#13TETRACYCLINE-INDUCIBLE EXPRESSION SYSTEM
#14RECOMBINANT PROTEIN PRODUCTION IN INSECTS
#15ANTI-MUC16 ANTIBODIES AND USES THEREOF
#16P21-CRE ANIMAL MODELS
#17AUXIN-INDUCIBLE DEGRON SYSTEM KIT AND USE THEREOF
#18NONHUMAN ANIMAL AND USE FOR SAME
#19TRANSGENIC NON-HUMAN ANIMAL CAPABLE OF CONTROLLING EXPRESSION OF TRANSCRIPTION FACTOR RP58
#20SYSTEMS AND METHODS FOR BATCH CULTIVATION OF NON-TRANSGENIC HETEROGAMETES
#21Tetracycline-inducible expression systems
#22MODELING ONCOLOGY ON DEMAND
#23GENETIC MODIFICATION OF PIGS FOR XENOTRANSPLANTATION
#24INTERLEUKIN-8 FOR MAINTENANCE OF HUMAN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME AND USES THEREOF
#25Compositions and methods for modulating neuronal excitability and motor behavior
#26INDUCIBLE MODIFICATION OF A CELL GENOME
#27Livestock animals with improved growth performance
#28FACTOR VIII OR FACTOR IX GENE KNOCKOUT RABBIT, METHOD FOR PREPARING SAME AND USE THEREOF
#29Gene expression system
#30ADAM6 KNOCKIN MICE
#31INDUCIBLE DISEASE MODELS METHODS OF MAKING THEM AND USE IN TISSUE COMPLEMENTATION
#32Non-human animals comprising a humanized coagulation factor 12 locus
#33Rodents With Conditional ACVR1 Mutant Alleles
#34Retinoic acid-inducible gene I promoter and compositions and methods relating to same
#35REPROGRAMMING METABOLISM BY INHIBITING VHL FOR TREATMENT OF NEURODEGENERATION
#36Anti-tumor properties of Dickkopf 3b
#37MODEL SYSTEM FOR MITOCHONDRIAL DYSFUNCTION AND METHODS OF USING THE SAME
#38Methods for autocatalytic genome editing and neutralizing autocatalytic genome editing and compositions thereof
#39Transgenic biosensor
#40ANIMAL MODELS FOR POLYCYSTIC KIDNEY DISEASE
#41Compositions and methods for modulating neuronal excitability and motor behavior
#42Conditional rodent Acvr1 mutant gene
#43Method for making a genetically modified mouse with an inducible ACVR1 mutation that causes ectopic bone formation
#44MYC-REPORTERS, CELLS CONTAINING MYC-REPORTERS AND METHODS OF USE THEREOF
#45Inducible modification of a cell genome
#46Poly-glutamine androgen receptor knock-in mouse models, reagents and methods
#47Nucleic Acid Construct Comprising a P16 Promoter Controlling Expression of a Transgene that Causes Apoptosis in Senescent Cells
#48Rodent embryonic stem cell with conditional ACVR1 mutant alleles
#49Increasing healthy lifespan and delaying progression of age-related phenotypes by selectively removing senescent cells
#50DNA editing using relatively long single-stranded DNA and CRISPR/Cas9 to increase success rate in methods for preparing transgenic embryos and animals
#51Treatment methods using DNA editing with single-stranded DNA
#52Anti-MUC16 antibodies and uses thereof
#53Genetic modification of pigs for xenotransplantation
#54Vectors and methods for targeted integration in loci comprising constitutively expressed genes
#55Generation of an inducible pericyte-specific CRE mouse model
#56ADAM12 inhibitors and their use against inflammation-induced fibrosis
#57Transgenic mouse for the assessment of thyroid hormone (TH) action
#58Tmem100 peptides and variants thereof and their use in treating or preventing diseases or conditions
#59SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF
#60Transgenic mouse model for conditional FKBP51 expression and related methods
#61GENE EXPRESSION SYSTEM
#62ANIMAL MODEL FOR STUDYING COMPLEX HUMAN DISEASES
#63Exon skipping technology in VCP disease
#64Expression cassette and vector comprising Alzheimer's disease-related mutant genes and cell line transformed by means of same
#65Nucleic acid construct for making a genetically modified rodent with an inducible ACVR1 mutation that causes ectopic bone formation
#66Tools and Methods for Targeting Oligonucleotide Repeat RNA Toxicity
#67Anti-tumor properties of Dickkopf 3b
#68ES Cell-Derived Mice From Diploid Host Embryo Injection
#69Compositions and methods for modulating neuronal excitability and motor behavior
#70Dosage compensating transgenes and cells
#71Role of a cluster of long noncoding RNA transcripts in protecting the heart from pathological hypertrophy
#72TRANSGENIC MOUSE MODEL FOR CONDITIONAL FKBP51 EXPRESSION AND RELATED METHODS
#73Transgenic animals capable of being induced to delete senescent cells
#74Inducible animal models of stress behavior
#75TRANSGENIC NON-HUMAN ANIMAL AND USES THEREOF
#76Transgenic biosensor
#77Anti-tumor properties of Dickkopf 3b
#78Biocontrol
#79Methods and compositions for the treatment of insulin-associated medical conditions
#80Miniature swine transgenic for one or more coagulation factors
#81Target molecules for transcriptional control systems
#82ADAM12 inhibitors and their use against inflammation-induced fibrosis
#83RbAp48 transgenic mice for drug discovery in age-related memory decline
#84Genetically modified mouse with an inducible gene with a mutant R206H exon 5 that has ectopic bone formation
#85Efficient sterilization of fish by disruption of germ cell development
#86Compositions and methods relating to non-human animals modified to promote production of selected gametes
#87Transgenic animals with customizable traits
#88Conditional Mst overexpressing construct and conditional myostatin overexpressing transgenic mouse
#89Transgenic fish and uses thereof
#90Regulatory proteins and inhibitors
#91Methods and uses of TIE2 binding and/or activating agents
#92In vivo gene regulation by the combination of knock-in-tetO sequence into the genome and tetracycline-controlled trans-suppressor (tTS) protein
#93Transgenic biosensors
#94Transgenic non-human animal and uses thereof
#95METHODS AND SYSTEMS FOR INDUCIBLE ABLATION OF NEURAL CELLS
#96ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis
#97Transgenic mouse conditionally expressing MMP12 for studying myelopoiesis, immunity and tumorigenesis
#98METHODS OF MONITORING ENDOPLASMIC RETICULUM (ER) STRESS RESPONSE
#99UBIQUITIN INTERACTING MOTIF PEPTIDES AS CANCER THERAPEUTICS
#100Compositions and methods relating to non-human animals modified to promote production of selected gametes
#101Targeted and regional cellular ablation in zebrafish
#102DHX36 / RHAU KNOCKOUT MICE AS EXPERIMENTAL MODELS OF MUSCULAR DYSTROPHY
#103Methods for Conditional and Inducible Transgene Expression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells
#104TetO-p16 transgenic mice
#105ASSAY FOR SCREENING ANTIDEPRESSANTS
#106Recombinant vaccinia virus having hepatitis C virus gene
#107Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof
#108Methods concerning PPAR delta and antagonists thereof
#109Transgenic fish and uses thereof
#110Transgenic animal with monocyte chemotactic protein 1 promoter
#111DEVELOPMENT STAGE-SPECIFIC LETHALITY SYSTEM FOR INSECT POPULATION CONTROL
#112Methods of identifying inhibitors of gene silencing in mammalian cells
#113MAO-B ELEVATION AS AN EARLY PARKINSON'S DISEASE BIOMARKER
#114Compositions and methods modulating MG29 for the treatment of diabetes
#115TRYPANOSOME RESISTANT NON-HUMAN TRANSGENIC ANIMAL
#116Transgenic Animal Model of Cancer and Methods of Use
#117Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes
#118LexA-based chemical-inducible gene expression system for use in transgenic animals
#119Methods of identifying small molecules for renewals, survival and migration of cardiac progenitors
#120Targeted and regional cellular ablation in zebrafish
#121Conditional Mst overexpressing construct and conditional myostatin overexpressing transgenic mouse
#122Fluorescent mouse model
#123Method for producing a transgenic pig using a hyper-methylated transposon
#124METHODS OF TREATING DISORDERS ASSOCIATED WITH FAT STORAGE
#125Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
#126Methods for Conditional and Inducible Transgene Espression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells
#127Modulators of RNF5 and Uses Thereof
#128Transgenic non-human animal models of apoptosis-mediated conditions
#129ALTERNATIVE OXIDASE AND USES THEREOF
#130Compositions comprising MG29 nucleic acids, polypeptides, and associated methods of use
#131DOUBLE-INDUCIBLE GENE ACTIVATION SYSTEM AND ITS APPLICATIONS
#132ES Cell-Derived Mice From Diploid Host Embryo Injection
#133Compositions and Methods Related to Controlled Gene Expression Using Viral Vectors
#134Conditional-stop dimerizable caspase transgenic animals
#135Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF)
#136Use of Fgf-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
#137Method for treating asthma and chronic obstructive pulmonary disease (COPD) comprising administering FGF2
#138Methods of identifying small molecules for renewal, survival and migration of cardiac progenitors
#139Alternative oxidase and uses thereof